OPKO Health Overview

  • Status
  • Public
  • Employees
  • 5,269
Employees
  • Stock Symbol
  • OPK
Stock Symbol
  • Investments
  • 40
  • Share Price
  • $3.61
  • (As of Monday Closing)

OPKO Health General Information

Description

Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

Contact Information

Formerly Known As
eXegenics, Cytoclonal Pharmaceutics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States
+1 (305) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OPKO Health Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.61 $3.70 $2.08 - $6.47 $2.48B 670M 5.96M $0.19

OPKO Health Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 3,096,816 2,888,298 1,227,930 1,929,891
Revenue 1,769,110 1,435,413 901,935 990,266
EBITDA 243,309 155,827 (191,352) (69,275)
Net Income 120,796 30,586 (314,925) (153,040)
Total Assets 2,519,575 2,473,063 2,309,272 2,451,072
Total Debt 293,415 294,575 315,974 213,464
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OPKO Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OPKO Health‘s full profile, request access.

Request a free trial

OPKO Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opk
Biotechnology
Miami, FL
5,269 As of 2020
00000
000000000 00000

00000000

, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
000000000000000
Dublin, OH
00000 As of 0000
0000

00000 00

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris n
000000000000000
Ahmedabad, India
00000 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OPKO Health Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardinal Health Corporation Dublin, OH 00000 0000
00000 000000000000 Private Equity-Backed Ahmedabad, India 00000 000.00 000000 - 000 000.00
0000000 0000000000 Corporation Yilan City, Taiwan 00
000000000 000000 Corporation Hyderabad, India 00000 00000 000000000 00000
000 000000 Corporate Backed or Acquired Rockland, MA 0000
You’re viewing 5 of 33 competitors. Get the full list »

OPKO Health Executive Team (21)

Name Title Board Seat Contact Info
Phillip Frost MD Chief Executive Officer & Chairman
Adam Logal Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer
Jane Hsiao Ph.D Chief Technology Officer, Technology & Board Member
Heriberto Regueira Director, Information Technology
Jennifer Dodd Senior Director Strategy & Business Development -Oncology Franchise
You’re viewing 5 of 21 executive team members. Get the full list »

OPKO Health Board Members (14)

Name Representing Role Since
00000 00 00.0 Self Board Member 000 0000
0000 00000 00.0 OPKO Health Chief Technology Officer, Technology & Board Member 000 0000
0000 000000000 Self Board Member 000 0000
000 00000 OPKO Health Board Member & Senior Vice President 000 0000
0000000 00000 00 OPKO Health Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 14 board members. Get the full list »

OPKO Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OPKO Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OPKO Health‘s full profile, request access.

Request a free trial

OPKO Health Investments & Acquisitions (40)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 02-Aug-2017 00000 00000 00 0000 Biotechnology
000 00000000(00000 06-Dec-2016 0000 000.00 Drug Discovery 0000 00000
00000 (00000 00000 14-Sep-2016 00000 0000000 Laboratory Services (Healthcare) 0000000 00000 00
0000000000 0000000 31-Aug-2016 000000000000000000 000.00 Drug Discovery 0000000 00000 00
Arno Therapeutics 16-Aug-2016 PIPE 000.00 Pharmaceuticals
You’re viewing 5 of 40 investments and acquisitions. Get the full list »

OPKO Health Subsidiaries (3)

Company Name Industry Location Founded
EirGen Pharma Distributors/Wholesale Waterford, Ireland 2005
00000000 000000000 Pharmaceuticals Nesher, Israel 0000
000-000000000 0000 Laboratory Services (Healthcare) Elmwood Park, NJ 0000
To view OPKO Health’s complete subsidiaries history, request access »

OPKO Health Exits (11)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 02-Aug-2017 00000 00000 00 0000 Completed
  • 11 buyers
000 00000000(00000 06-Dec-2016 0000 000.00 Completed
  • 4 buyers
0000 000000000000 16-Aug-2016 0000 000.00 Completed
  • 6 buyers
000000 00000000000 27-Jul-2015 0000 00.000 Completed
  • 2 buyers
MabVax Therapeutics 10-Apr-2015 PIPE 000.00 Completed
You’re viewing 5 of 11 exits. Get the full list »